glp-1 receptor agonist medication How medications are transforming diabetes and weight loss treatment GLP-1 Receptor Agonists as Treatments

The randomized, double-blind, placebo-controlled Evaluating the Effects of the Novel GLP-1 Analogue Liraglutide in Alzheimers Disease (ELAD) trial led by Prof

[DOI] [PMC free article] [PubMed] [Google Scholar] 9.von Loeffelholz C., Roth J., Coldewey S., Birkenfeld A

Earlier versions of GLP-1 drugs, such as exenatide (Byetta), increased the risk for pancreatic cancer or certain types of thyroid cancer and even instances of autoimmunity

Individual safety findings for one molecule dont necessarily predict class-wide effects, says Finer, safety signals often relate to specific structural features or off-target activities rather than the primary mechanism of action. He thinks oral GLP-1 drugs have the potential for better dose titration, which might help control the current, mainly gastrointestinal, side-effects of the injectable peptides